in vitro-treated bone marrow transplantation

PROCEDURE19 trials

Sponsors

Montefiore Medical Center, Memorial Sloan Kettering Cancer Center, Barbara Ann Karmanos Cancer Institute, Abramson Cancer Center at Penn Medicine, Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

Conditions

Breast CancerCancerChildhood Germ Cell TumorChronic Myeloproliferative DisordersExtragonadal Germ Cell TumorGraft Versus Host DiseaseHead and Neck CancerKidney Cancer

Phase 1

Bone Marrow Transplantation With Specially Treated Bone Marrow in Treating Patients With Hematologic Cancer That Have Not Responded to Previous Therapy

CompletedNCT00005988

Dana-Farber Cancer InstituteGraft Versus Host Disease, Leukemia, Lymphoma +2

Start: 2000-02-29End: 2002-03-08Updated: 2017-04-04

Peripheral Stem Cell Transplantation With or Without Stromagen Following Chemotherapy in Treating Women With Metastatic Breast Cancer

CompletedNCT00003877

Roswell Park Cancer InstituteBreast Cancer

Start: 1998-09-30End: 2000-12-31Target: 30Updated: 2011-03-07

Ex Vivo Expansion of Mafosfamide Purged CD34+ Cells in Patients With Acute Leukemia

TerminatedNCT00245115

Sidney Kimmel Comprehensive Cancer Center at Johns HopkinsLeukemia

Start: 2005-10-31End: 2012-01-31Updated: 2018-08-23

Donor Mesenchymal Stem Cell Infusion in Treating Patients With Acute or Chronic Graft-Versus-Host Disease After Undergoing a Donor Stem Cell Transplant

CompletedNCT00361049

Case Comprehensive Cancer CenterCancer

Start: 2004-09-30End: 2010-11-30Updated: 2010-11-05

Phase 2

Combination Chemotherapy Followed by Bone Marrow Transplantation in Treating Patients With Rare Cancer

CompletedNCT00002515

Memorial Sloan Kettering Cancer CenterChildhood Germ Cell Tumor, Extragonadal Germ Cell Tumor, Head and Neck Cancer +8

Start: 1992-10-31End: 2005-04-30Updated: 2013-06-24

T-cell Depleted Bone Marrow and G-CSF Stimulated Peripheral Stem Cell Transplantation From Related Donors in Treating Patients With Leukemia, Lymphoblastic Lymphoma, Myelodysplastic Syndrome, or Aplastic Anemia

CompletedNCT00002718

Memorial Sloan Kettering Cancer CenterLeukemia, Lymphoma, Myelodysplastic/Myeloproliferative Neoplasms +1

Start: 1995-11-30End: 2008-10-31Updated: 2015-12-23

Sargramostim Following Allogeneic Bone Marrow Transplantation in Treating Patients With Chronic Myelogenous Leukemia

TerminatedNCT00002778

Sidney Kimmel Comprehensive Cancer Center at Johns HopkinsLeukemia

Start: 1995-02-28End: 2010-07-31Target: 40Updated: 2011-07-20

Treatment of Bone Marrow to Prevent Graft-Versus-Host Disease in Patients With Acute or Chronic Leukemia Undergoing Bone Marrow Transplantation

CompletedNCT00004255

Chimeric TherapiesGraft Versus Host Disease, Leukemia, Myelodysplastic Syndromes

Start: 2000-03-31End: 2003-05-31Updated: 2013-07-10

Combination Chemotherapy Followed by Bone Marrow or Peripheral Stem Cell Transplantation in Treating Patients With Refractory Hodgkin's Disease or Non-Hodgkin's Lymphoma

CompletedNCT00002461

Montefiore Medical CenterLymphoma

Start: 1988-04-30End: 1991-07-31Updated: 2018-08-17

Chemotherapy and Bone Marrow Transplantation in Treating Patients With Chronic Myelogenous Leukemia

CompletedNCT00002592

Abramson Cancer Center at Penn MedicineLeukemia

Start: 1993-06-30End: 2002-08-31Target: 40Updated: 2015-01-14

Donor Bone Marrow Transplantation in Treating Patients With Hematologic Cancer

CompletedNCT00003960

Sidney Kimmel Comprehensive Cancer Center at Johns HopkinsLeukemia, Multiple Myeloma and Plasma Cell Neoplasm, Myelodysplastic Syndromes

Start: 1998-04-30End: 2001-09-30Target: 36Updated: 2014-05-02

Bone Marrow Transplantation in Treating Patients With Leukemia, Myelodysplasia, or Lymphoblastic Lymphoma

CompletedNCT00003187

Virginia Commonwealth UniversityLeukemia, Lymphoma, Myelodysplastic Syndromes

Start: 1995-05-31End: 2005-02-28Updated: 2010-02-24

Chemotherapy Plus Bone Marrow Transplantation in Treating Patients With Refractory Non-Hodgkin's Lymphoma, Hodgkin's Disease, or Multiple Myeloma

CompletedNCT00002552

Barbara Ann Karmanos Cancer InstituteLymphoma, Multiple Myeloma and Plasma Cell Neoplasm

Start: 1993-10-31End: 2003-10-31Target: 40Updated: 2013-04-09

Removal of T Cells to Prevent Graft-Versus-Host Disease in Patients Undergoing Bone Marrow Transplantation

TerminatedNCT00005641

H. Lee Moffitt Cancer Center and Research InstituteChronic Myeloproliferative Disorders, Graft Versus Host Disease, Leukemia +2

Start: 1997-09-30End: 2000-09-30Updated: 2012-12-11

Bone Marrow Transplantation in Treating Patients With Hematologic Cancer

CompletedNCT00005854

Fred Hutchinson Cancer CenterLeukemia, Lymphoma, Multiple Myeloma and Plasma Cell Neoplasm +1

Start: 1999-12-31End: 2000-10-31Updated: 2011-11-30

Chemotherapy, Radiation Therapy, Immunotherapy, and Bone Marrow Transplantation in Treating Patients With Neuroblastoma

CompletedNCT00002634

Memorial Sloan Kettering Cancer CenterNeuroblastoma

Start: 1995-02-28End: 2004-09-30Target: 45Updated: 2013-07-03

Phase 3

Bone Marrow Transplantation in Treating Patients With Acute Leukemia in First or Second Remission

CompletedNCT00002534

Memorial Sloan Kettering Cancer CenterLeukemia

Start: 1993-05-31End: 2003-04-30Updated: 2013-06-26

Bone Marrow Transplantation in Treating Patients With Leukemia

WithdrawnNCT00006451

Masonic Cancer Center, University of MinnesotaGraft Versus Host Disease, Leukemia, Lymphoma

Start: 1996-04-30End: 2000-11-30Updated: 2020-01-03

Laboratory-Treated Donor Bone Marrow in Treating Patients Who Are Undergoing a Donor Bone Marrow Transplant for Hematologic Cancer

CompletedNCT00265837

Sidney Kimmel Comprehensive Cancer Center at Johns HopkinsGraft Versus Host Disease, Leukemia, Lymphoma +3

Start: 2002-12-31End: 2007-08-31Updated: 2014-04-17

Related Papers

The anti-GD2 monoclonal antibody naxitamab plus GM-CSF for relapsed or refractory high-risk neuroblastoma: a phase 2 clinical trial

Nature Communications2025-02-1415 citations